Download PDF
Am J Perinatol 2021; 38(03): 273-277
DOI: 10.1055/s-0039-1696674
Original Article

Comparing Glucose Challenge Test Screening Thresholds in Obese and Overweight Gravidas

Caitlin MacGregor
1   University of Chicago Pritzker School of Medicine, Chicago, Illinois
,
Phin Has
2   Brown University, Providence, Rhode Island
,
Deanna Nardella
3   Brown University Warren Alpert Medical School, Providence, Rhode Island
,
Erika Werner
3   Brown University Warren Alpert Medical School, Providence, Rhode Island
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Objective Given the paucity of contemporary data examining glucose challenge test (GCT), thresholds for gestational diabetes (GDM) screening in obese and overweight women, we sought to compare the sensitivity and testing characteristics of different screen positive GCT cut-offs in women with a prepregnancy body mass index (BMI) ≥ 25 kg/m2.

Study Design This is a retrospective cohort study of obese and overweight women with singleton pregnancies who underwent GCT between 24 and 296/7 weeks and had a value between 130 and 199 mg/dL necessitating a 3-hour glucose tolerance test (GTT). Exclusion criteria were pregestational diabetes mellitus, multigestation, use of diabetes medications, and bariatric surgery.

Results Between August 2015 and January 2016, 19% (n = 496) of women with a BMI ≥ 25 kg/m2 required a GTT to test for GDM, 27.8% (n = 138) of whom were diagnosed with GDM. Mean age was 30 years, mean BMI = 31.6 kg/m2, and 30.4% were Hispanic. The 130 mg/dL threshold compared with 140 mg/dL was more sensitive (absolute increase: 11.3%, 95% confidence interval [CI]: 6.7–17%), but less specific (absolute decrease: 6.4%, 95% CI: 5.5–7.5%).

Conclusion Shared decision making should be used to determine GCT cut-offs as some patients may prefer to undergo a GTT rather than miss a diagnosis of GDM.

Keywords

gestational diabetes - obesity - pregnancy - screening test


Publication History

Received: 15 April 2019

Accepted: 26 July 2019

Article published online:
06 September 2019

© 2019. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Committee on Practice Bulletins–Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol 2013; 122 (2, Pt 1): 406-416
    CrossrefPubMedGoogle Scholar
  • 2 Landon MB, Gabbe SG. Gestational diabetes mellitus. Obstet Gynecol 2011; 118 (06) 1379-1393
    CrossrefPubMedGoogle Scholar
  • 3 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29 (Suppl. 01) S43-S48
    CrossrefPubMedGoogle Scholar
  • 4 Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. ; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352 (24) 2477-2486
    CrossrefPubMedGoogle Scholar
  • 5 Landon MB, Spong CY, Thom E. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361 (14) 1339-1348
    CrossrefPubMedGoogle Scholar
  • 6 Esakoff TF, Cheng YW, Caughey AB. Screening for gestational diabetes: different cut-offs for different ethnicities?. Am J Obstet Gynecol 2005; 193 (3, Pt 2): 1040-1044
    CrossrefPubMedGoogle Scholar
  • 7 Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307 (05) 491-497
    CrossrefPubMedGoogle Scholar
  • 8 American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 549: obesity in pregnancy. Obstet Gynecol 2013; 121 (01) 213-217
    CrossrefPubMedGoogle Scholar
  • 9 Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144 (07) 768-773
    CrossrefPubMedGoogle Scholar
  • 10 Hartling L, Dryden DM, Guthrie A. et al. Screening and diagnosing gestational diabetes mellitus. Evid Rep Technol Assess (Full Rep) 2012; (210) 1-327
    PubMedGoogle Scholar
  • 11 Coustan DR. Methods of screening for and diagnosing of gestational diabetes. Clin Perinatol 1993; 20 (03) 593-602
    CrossrefPubMedGoogle Scholar
  • 12 Donovan L, Hartling L, Muise M, Guthrie A, Vandermeer B, Dryden DM. Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2013; 159 (02) 115-122
    CrossrefPubMedGoogle Scholar
  • 13 Honein MA, Devine O, Sharma AJ. et al. Modeling the potential public health impact of prepregnancy obesity on adverse fetal and infant outcomes. Obesity (Silver Spring) 2013; 21 (06) 1276-1283
    CrossrefPubMedGoogle Scholar
  • 14 Grobman WA, Bailit JL, Rice MM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Can differences in obstetric outcomes be explained by differences in the care provided? The MFMU Network APEX study. Am J Obstet Gynecol 2014; 211 (02) 147.e1-147.e16
    CrossrefPubMedGoogle Scholar